MARAVAI LIFESCIENCES HOLDINGS INC
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
| Maravai LifeSciences Holdings, Inc. | |
| By: | /s/ William E. Martin, III |
| Name: | William E. Martin, III |
| Title: | Chief Executive Officer |
Date: February 29, 2024
Pursuant to the requirements of the Securities and Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicted.
| Signature | Title | Date |
|---|---|---|
| Chief Executive Officer (Principal Executive Officer) | February 29, 2024 | |
| /s/ William E. Martin, III | ||
| William E. Martin, III | ||
| /s/ Kevin Herde | Chief Financial Officer (Principal Financial and Accounting Officer) | February 29, 2024 |
| Kevin Herde | ||
| /s/ Carl Hull | Executive Chairman of the Board | February 29, 2024 |
| Carl Hull | ||
| /s/ Anat Ashkenazi | Director | February 29, 2024 |
| Anat Ashkenazi | ||
| /s/ Sean Cunningham | Director | February 29, 2024 |
| Sean Cunningham | ||
| /s/ Benjamin Daverman | Director | February 29, 2024 |
| Benjamin Daverman | ||
| /s/ John DeFord | Director | February 29, 2024 |
| John DeFord, Ph.D. | ||
| /s/ Susannah Gray | Director | February 29, 2024 |
| Susannah Gray | ||
| /s/ Jessica Hopfield | Director | February 29, 2024 |
| Jessica Hopfield, Ph.D. | ||
| /s/ Gregory T. Lucier | Director | February 29, 2024 |
| Gregory T. Lucier | ||
| /s/ Luke Marker | Director | February 29, 2024 |
| Luke Marker | ||
| /s/ Constantine Mihas | Director | February 29, 2024 |
| Constantine Mihas | ||
| /s/ Murali K. Prahalad | Director | February 29, 2024 |
| Murali K. Prahalad | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.